Key Metrics
3.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
55
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.83 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Oncology
SJR
- Q3 Oncology
- Q3 Pharmacology
- Q3 Infectious Diseases
- Q3 Pharmacology (medical)
- Q3 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.63
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
15%
4 to 6 months
56%
7 to 9 months
20%
Above 9 months
10%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Cancer
- Infective endocarditis
- Colistin
- Staphylococcus aureus
- Antimicrobial stewardship
- Escherichia coli
- Case series
- Vancomycin
- Klebsiella pneumoniae
- Second-line therapy
- Voriconazole
- Regorafenib
- Pseudomonas aeruginosa
- Overall survival
- Systematic review
- Adult patients
- Bacteremia
- Paclitaxel
- Antibiotic prescribing
- Genotype
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Journal of Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Therapy-related hand-foot syndrome: a review
- 2 Dec 24
- Journal of Chemotherapy
-
Full paper
LncRNA-FGD5-AS1 promotes 5-Fu resistance of cervical cancer cells through modulating the miR-130a-3p-YTHDF2 axis
- 30 Nov 24
- Journal of Chemotherapy
-
Full paper
The acceleration of cisplatin resistance in colorectal cancer by lncRNA NORAD through regulation of miR-106a-5p/Cyclin D1 axis
- 30 Nov 24
- Journal of Chemotherapy
-
Full paper
Ribociclib-induced autoimmune-like hepatitis: a case report
- 22 Nov 24
- Journal of Chemotherapy
-
Full paper
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey
- 17 Nov 24
- Journal of Chemotherapy
-
Full paper
Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
- 1 Nov 24
- Journal of chemotherapy (Florence, Italy)
Scite analysis
Powered by scite_
3.5k articles received 24.2k citations see all
- 1,169 Supporting
- 21,781 Mentioning
- 226 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 5 Corrections
- 3 Errata
- 0 Expression of Concern
FAQs
How long has Journal of Chemotherapy been actively publishing?
Journal of Chemotherapy has been in operation since 1989 till date.
What is the publishing frequency of Journal of Chemotherapy ?
Journal of Chemotherapy published with a Bi-monthly frequency.
How many articles did Journal of Chemotherapy publish last years ?
In 2023, Journal of Chemotherapy published 74 articles.
What is the eISSN & pISSN for Journal of Chemotherapy ?
For Journal of Chemotherapy,eISSN is 1973-9478 and pISSN is1120-009X.
What is Citescore for Journal of Chemotherapy ?
Citescore for Journal of Chemotherapy is 3.1.
What is H index for Journal of Chemotherapy ?
H index for Journal of Chemotherapy is 55.
What is SNIP score for Journal of Chemotherapy ?
SNIP score for Journal of Chemotherapy is 0.63.
What is the SJR for Journal of Chemotherapy ?
SJR for Journal of Chemotherapy is Q3.
Who is the publisher of Journal of Chemotherapy ?
TAYLOR & FRANCIS LTD is the publisher of Journal of Chemotherapy.